a mucin 16 bispecific t cell-engaging antibody for the treatment of ovarian cancer
Published 2 years ago • 847 plays • Length 49:07Download video MP4
Download video MP3
Similar videos
-
30:36
bispecific antibodies to engage vγ9vδ2-t cells for cancer immunotherapy
-
31:11
targeting tumor associated macrophages in ovarian cancer
-
5:33
context therapeutics announces bispecific antibody clinical candidate to treat cldn6 cancers
-
1:30
muc16 inhibitor clinical trial
-
5:27
amg 160: a psma-targeted, bispecific t-cell engager immune therapy for mcrpc
-
2:43
phase i dose escalation of imc-f106c, a prame × cd3 immtac bispecific protein in solid tumors
-
1:00
breaking news on the ovarian cancer front! #cancerawareness #breakingnews #beatcancer #curecancer
-
59:29
immunotherapy update for ovarian cancer
-
6:06
bispecific antibodies for mm
-
2:18
a promising treatment for ovarian cancer
-
18:02
understanding ca125, secrets of ca125/ muc16 , how i trained my-self about ca125/ muc16 , part-1
-
0:42
hpn328, a tri-specific t-cell engager, in sclc and neuroendocrine cancers
-
9:12
ovarian cancer explained (including subtypes)
-
0:31
essential tests for ovarian cancer diagnosis | key tests explained | dr aditi bhatt
-
29:28
evaluating the options: assessing emerging bispecific antibody treatments for follicular lymphoma
-
0:59
sym015: met antibody mixture for advanced solid tumors
-
21:00
future directions for ovarian cancer research - dr tarek meniawy
-
3:57
management of b-cell malignancies in the face of covid-19